Verborgh C, Van der Auwera D, Camu F
Department of Anaesthesia, Flemish University of Brussels School of Medicine, University Medical Center, Belgium.
Br J Anaesth. 1987 Sep;59(9):1134-9. doi: 10.1093/bja/59.9.1134.
The analgesic and cardiorespiratory effects of meptazinol 90 mg, given by the extradural or the i.m. route, were studied in 32 postoperative patients. Plasma meptazinol concentrations were measured in five patients in each treatment group. Evaluation using a linear analogue scale indicated that there were significant differences between the groups in the onset, quality and duration of pain relief, with the extradural route being superior to the i.m. route in each instance. The difference in quality of pain relief was not related to the resultant plasma meptazinol concentrations, which were similar in the two groups. Ventilatory rate was decreased equally in both groups in parallel with pain relief, but no incidence of overt respiratory depression was noted. Meptazinol produced no meaningful changes in measured cardiovascular variables, and side effects were minimal in both groups.
对32例术后患者研究了硬膜外或肌肉注射90毫克美普他酚的镇痛及心肺效应。在每个治疗组的5例患者中测量了血浆美普他酚浓度。使用线性模拟量表进行的评估表明,两组在疼痛缓解的起效时间、质量和持续时间方面存在显著差异,在每种情况下硬膜外途径均优于肌肉注射途径。疼痛缓解质量的差异与两组相似的血浆美普他酚浓度无关。两组的通气率均随着疼痛缓解而同等程度降低,但未观察到明显的呼吸抑制发生率。美普他酚对所测心血管变量未产生有意义的变化,且两组的副作用均最小。